Drug · DIN 02416751
PREGABALIN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since November 22, 2013.
- Drug Identification Number (DIN)
- 02416751
- Company (DIN owner)
- Alembic Pharmaceuticals LimitedVadodara, Gujarat, India
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Pregabalin N02BF02
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PREGABALIN | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 6, 2023: NOC 32305Supplement to an Abbreviated New Drug Submission (SANDS) · Product Monograph reformatted to the Master Template. Update to the Package Insert
- November 22, 2013: NOC 14939Abbreviated New Drug Submission (ANDS)
Other DINs named PREGABALIN
- DIN 02396483 · Marketed
- DIN 02396505 · Marketed
- DIN 02396513 · Marketed
- DIN 02396521 · Marketed
- DIN 02396548 · Marketed
- DIN 02403692 · Marketed
- DIN 02403706 · Marketed
- DIN 02403714 · Marketed
- DIN 02403722 · Marketed
- DIN 02403730 · Marketed
- DIN 02405539 · Marketed
- DIN 02405547 · Marketed
- DIN 02405555 · Marketed
- DIN 02405563 · Marketed
- DIN 02405598 · Marketed
- DIN 02474352 · Marketed
- DIN 02474360 · Marketed
- DIN 02474379 · Marketed
- DIN 02474387 · Marketed
- DIN 02376946 · Cancelled Pre Market